Impact of preoperative radiotherapy on the risk of postpancreatectomy haemorrhage and major morbidity after resection of pancreatic adenocarcinoma including arterial divestment or arterial resection
Thomas F Stoop(Karolinska University Hospital), T Sugawara, Oskar Franklin(University of Colorado Anschutz Medical Campus), Bas Groot Koerkamp, Mahsoem Ali(Amsterdam Neuroscience), Wouter te Riele(St. Antonius Ziekenhuis), Olivier R. Busch(Amsterdam Neuroscience), Joris I. Erdmann(Amsterdam University Medical Centers), van Eijck(Erasmus MC Cancer Institute), Freek R. van ‘t Land(Erasmus MC Cancer Institute), Niccolò Napoli(University of Pisa), Thilo Welsch(Universität Hamburg), Ahmer Sultan(Mayo Clinic), Leonard W F Seelen(St. Antonius Ziekenhuis), R F de Wilde(Erasmus MC Cancer Institute), T Hackert(Universität Hamburg), Richard D Schulick(University of Colorado Anschutz Medical Campus), Freek Daams(Vrije Universiteit Amsterdam), Hiroyuki Ishida(University of Colorado Anschutz Medical Campus), Mark J Truty(Mayo Clinic), Christopher L Wolfgang(City University of New York), Marc G Besselink(Amsterdam Neuroscience), I F Rompen, D Brock Hewitt(City University of New York), G Kazemier, Michael L Kendrick(Mayo Clinic), Ernesto Sparrelid(Karolinska University Hospital), Marie Cappelle(Erasmus MC Cancer Institute), I Quintus Molenaar(St. Antonius Ziekenhuis), Marco Del Chiaro(University of Colorado Anschutz Medical Campus), S Rodriguez Franco, P Larsson, O H Fiete Gehrisch(Universität Hamburg), Michael Ginesini(University of Pisa), Hjalmar C van Santvoort(St. Antonius Ziekenhuis), Ugo Boggi(University of Pisa), Faik G Uzunoglu(Universität Hamburg), Cornelius A Thiels(Mayo Clinic), Poya Ghorbani(Karolinska University Hospital), C Croce, Rimon Dankha(Karolinska University Hospital), Ammar A Javed(City University of New York), Jennifer L. Leiting(Mayo Clinic)
Cited by 0
Related Papers
Preoperative Chemoradiotherapy for Esophageal or Junctional Cancer
|New England Journal of Medicine|2012|5.5k
Neoadjuvant chemoradiotherapy plus surgery versus surgery alone for oesophageal or junctional cancer (CROSS): long-term results of a randomised controlled trial
|The Lancet Oncology|2015|2.6k
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
FOLFIRINOX for locally advanced pancreatic cancer: a systematic review and patient-level meta-analysis
|The Lancet Oncology|2016|914